Bioactivity of a Novel Peptide,QUB-2392 on Human Leukaemia Cell lines

Activity: Talk or presentationOral presentation

Description

1. Symposium: Presentation on Novel Bioactive Peptide QUB-2392 (January 2025)
• Significance: Shared insights into the bioactivity of QUB-2392 and its potential mechanism of action at London South Bank University.
• Contribution: Engaged with colleagues and focusing on the mechanisms by which QUB-2392 may influence cancer therapy.
• Impact: Fostered discussions around the application of anticancer peptides, enhancing collaboration from the Cancer Biology and Therapy Group.
Period8 Jan 2025
Held atHuman Sciences
Degree of RecognitionLocal